These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19699489)

  • 21. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
    Liu X; Wen F; Yang J; Chen L; Wei YQ
    Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic approaches to unravel the complexity of schizophrenia.
    Martins-de-Souza D; Guest PC; Rahmoune H; Bahn S
    Expert Rev Proteomics; 2012; 9(1):97-108. PubMed ID: 22292827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
    Prabakaran S; Swatton JE; Ryan MM; Huffaker SJ; Huang JT; Griffin JL; Wayland M; Freeman T; Dudbridge F; Lilley KS; Karp NA; Hester S; Tkachev D; Mimmack ML; Yolken RH; Webster MJ; Torrey EF; Bahn S
    Mol Psychiatry; 2004 Jul; 9(7):684-97, 643. PubMed ID: 15098003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Schizophrenia--neurodevelopmental and neurodegenerative theory revisited].
    Szulc A; Galińska B; Czernikiewicz A
    Psychiatr Pol; 2005; 39(2):249-58. PubMed ID: 15881620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population.
    Wan C; Yang Y; Feng G; Gu N; Liu H; Zhu S; He L; Wang L
    Neurosci Lett; 2005 Nov; 388(3):126-31. PubMed ID: 16039057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White matter changes in schizophrenia: evidence for myelin-related dysfunction.
    Davis KL; Stewart DG; Friedman JI; Buchsbaum M; Harvey PD; Hof PR; Buxbaum J; Haroutunian V
    Arch Gen Psychiatry; 2003 May; 60(5):443-56. PubMed ID: 12742865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The state of proteome profiling in the fungal genus Aspergillus.
    Kim Y; Nandakumar MP; Marten MR
    Brief Funct Genomic Proteomic; 2008 Mar; 7(2):87-94. PubMed ID: 18187513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori: a role in schizophrenia?
    Yilmaz Y; Gul CB; Arabul M; Eren MA
    Med Sci Monit; 2008 Jul; 14(7):HY13-6. PubMed ID: 18591925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteome analysis of schizophrenia brain tissue.
    Martins-De-Souza D; Dias-Neto E; Schmitt A; Falkai P; Gormanns P; Maccarrone G; Turck CW; Gattaz WF
    World J Biol Psychiatry; 2010 Mar; 11(2):110-20. PubMed ID: 20109112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder.
    Gogos JA
    Int Rev Neurobiol; 2007; 78():397-422. PubMed ID: 17349868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is schizophrenia a neurodegenerative disorder?
    Rund BR
    Nord J Psychiatry; 2009; 63(3):196-201. PubMed ID: 19235629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent advances in the genetics of schizophrenia and the practical implications of the results].
    Réthelyi J; Polgár P; Czobor P; Bitter I
    Psychiatr Hung; 2008; 23(3):152-65. PubMed ID: 18956622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroproteomics of the synapse and drug addiction.
    Abul-Husn NS; Devi LA
    J Pharmacol Exp Ther; 2006 Aug; 318(2):461-8. PubMed ID: 16644901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An approach to handling and interpretation of ambiguous data in transcriptome and proteome comparisons.
    Irmler M; Hartl D; Schmidt T; Schuchhardt J; Lach C; Meyer HE; Hrabé de Angelis M; Klose J; Beckers J
    Proteomics; 2008 Mar; 8(6):1165-9. PubMed ID: 18283664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of proteomics for the identification of novel drug targets in brain diseases.
    Morón JA; Devi LA
    J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders.
    Kempf L; Hussain N; Potash JB
    Int Rev Psychiatry; 2005 Feb; 17(1):9-19. PubMed ID: 16194767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gene-expression profiling in schizophrenia: an overview].
    Verveer J; Huizer K; Fekkes D; van Beveren NJ
    Tijdschr Psychiatr; 2007; 49(1):7-16; discussion 17-9. PubMed ID: 17225200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methods for transcriptome and proteome research: applications for studying the biology of reproduction in cattle].
    Wolf E; Hiendleder S; Bauersachs S; Fröhlich T; Sinowatz F; Blum H; Arnold GJ
    Berl Munch Tierarztl Wochenschr; 2006; 119(1-2):7-16. PubMed ID: 16450702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding complex transcriptome dynamics in schizophrenia and other neurological diseases using RNA sequencing.
    Wang X; Cairns MJ
    Int Rev Neurobiol; 2014; 116():127-52. PubMed ID: 25172474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.